TransMedics Group, Inc. (TMDX) Operating margin 2018–2025
TransMedics Group, Inc. (TMDX) operating margin by fiscal year — reported operating income divided by reported revenue.
17.9%FY2025 · since FY2018: -138.1% → 17.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 17.9% | +9.4 pp |
| FY2024 | 8.5% | +20.4 pp |
| FY2023 | -11.9% | +21.7 pp |
| FY2022 | -33.6% | +92.0 pp |
| FY2021 | -125.6% | -32.6 pp |
| FY2020 | -93.0% | +21.5 pp |
| FY2019 | -114.5% | +23.5 pp |
| FY2018 | -138.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TMDX financial trends
TMDX RevenueTMDX Net incomeTMDX Net marginTMDX Gross profitTMDX Gross marginTMDX Operating incomeTMDX Operating cash flowTMDX Free cash flowTMDX Capital expendituresTMDX Return on equityTMDX Stock buybacksTMDX Dividends paidTMDX Total assetsTMDX Total liabilitiesTMDX Shareholders’ equityTMDX overview →